Wire · opportunities
Biora Therapeutics Receives Approval for First-in-Human Trial of BioJet™ Oral Biologic ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 4 November 2026 · Fusion42 review
Biora Therapeutics has received Human Research Ethics Committee approval in Australia for a first-in-human trial of its BioJet oral capsule, a needle-free device designed to deliver biologic drugs like adalimumab through the small intestine for systemic uptake. This trial will assess safety, tolerability, and pharmacokinetics compared to traditional injection methods.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You must prepare for a shift in biologic drug delivery as oral capsules replace injections; BioJet's approval signals a new route to market that cuts patient barriers. Immediate focus on collaborations with drug makers and clinical setups will secure early adopter advantage.
◆ Coverage
1 source · 4 Nov 2026
◆ Related on Wire
◆ Topics